Clinical Trial Update: Ocular Growth Factors Profile in Proliferative Retinopathies Before and After Intravitreal Bevacizumab [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating ocular growth factors in proliferative retinopathies before and after intravitreal bevacizumab has completed. It targeted prol…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Age-related Macular Degeneration
• Proliferative Diabetic Retinopathy

Drugs mentioned

• Bevacizumab (bevacizumab)

Snippet

Sponsor: Ophthalmological Association Edelweiss | Conditions: Proliferative Diabetic Retinopathy, Age Related Macular Degeneration | Phase 2 | Status: COMPLETED